Schneider B - Search Results

1

Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: a safety, feasibility, and efficacy study from the Hoosier Oncology Group.

Jalal S, Bedano P, Einhorn L, Bhatia S, Ansari R, Bechar N, Koneru K, Govindan R, Wu J, Yu M, Schneider B, Hanna N. Jalal S, et al. Among authors: schneider b. J Thorac Oncol. 2010 Dec;5(12):2008-11. doi: 10.1097/JTO.0b013e3181f77b6e. J Thorac Oncol. 2010. PMID: 21102263 Free article.

2

Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer: a Hoosier Oncology Group study.

Schneider BP, Ganjoo KN, Seitz DE, Picus J, Fata F, Stoner C, Calley C, Loehrer PJ. Schneider BP, et al. Oncology. 2003;65(3):218-23. doi: 10.1159/000074474. Oncology. 2003. PMID: 14657595 Clinical Trial.

3

Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.

Schneider BP, Kesler KA, Brooks JA, Yiannoutsos C, Einhorn LH. Schneider BP, et al. J Clin Oncol. 2004 Apr 1;22(7):1195-200. doi: 10.1200/JCO.2004.07.102. J Clin Oncol. 2004. PMID: 15051766

4

Angiogenesis of breast cancer.

Schneider BP, Miller KD. Schneider BP, et al. J Clin Oncol. 2005 Mar 10;23(8):1782-90. doi: 10.1200/JCO.2005.12.017. J Clin Oncol. 2005. PMID: 15755986 Review. No abstract available.

5

A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-alpha2b in patients with solid tumors.

Schneider B, Fukunaga A, Murry D, Yoder C, Fife K, Foster A, Rosenberg L, Kelich S, Li L, Sweeney C. Schneider B, et al. Cancer Chemother Pharmacol. 2007 Feb;59(2):261-8. doi: 10.1007/s00280-006-0264-z. Epub 2006 May 30. Cancer Chemother Pharmacol. 2007. PMID: 16733646 Clinical Trial.

6

Drug insight: VEGF as a therapeutic target for breast cancer.

Schneider BP, Sledge GW Jr. Schneider BP, et al. Nat Clin Pract Oncol. 2007 Mar;4(3):181-9. doi: 10.1038/ncponc0740. Nat Clin Pract Oncol. 2007. PMID: 17327858 Review.

7

Is the blood-brain barrier relevant in metastatic germ cell tumor?

Azar JM, Schneider BP, Einhorn LH. Azar JM, et al. Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):163-6. doi: 10.1016/j.ijrobp.2007.02.042. Int J Radiat Oncol Biol Phys. 2007. PMID: 17707269 Review.

8

A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.

Kesler KA, Rieger KM, Hammoud ZT, Kruter LE, Perkins SM, Turrentine MW, Schneider BP, Einhorn LH, Brown JW. Kesler KA, et al. Ann Thorac Surg. 2008 Feb;85(2):371-8. doi: 10.1016/j.athoracsur.2007.09.020. Ann Thorac Surg. 2008. PMID: 18222228

9

Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.

Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M, Perez EA, Cobleigh M, Shenkier T, Edgerton S, Miller KD; ECOG 2100. Schneider BP, et al. J Clin Oncol. 2008 Oct 1;26(28):4672-8. doi: 10.1200/JCO.2008.16.1612. J Clin Oncol. 2008. PMID: 18824714 Free PMC article. Clinical Trial.

10

Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion.

Carpenter JS, Yu M, Wu J, Von Ah D, Milata J, Otte JL, Johns S, Schneider B, Storniolo AM, Salomon R, Desta Z, Cao D, Jin Y, Philips S, Skaar TC. Carpenter JS, et al. Among authors: schneider b. Menopause. 2009 Jul-Aug;16(4):644-52. doi: 10.1097/gme.0b013e318199e9f6. Menopause. 2009. PMID: 19265726 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,362 results

Search Page

Filters